(1)
Heim, J.; Vasquez, J. G.; Schenkel, B.; Bhatia, N. Patients’ Quality of Life in a Phase 4 Real-World Study of Tildrakizumab in Moderate-to-Severe Plaque Psoriasis. J of Skin 2023, 7, s135.